Profusa (PFSA) Income from Continuing Operations (2022 - 2026)
Profusa's (PFSA) quarterly Income from Continuing Operations came in at 4606000.0 in Q1 2026, down 311.28% year-on-year from 2180013.97 in Q1 2025, and up 0.9% quarter-over-quarter from 4648000.0 in Q4 2025.
Profusa (PFSA) Income from Continuing Operations (2022 - 2026) Analysis & Trends
Profusa's Income from Continuing Operations history runs 5 years deep, the most recent figure standing at 4606000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 311.28% year-over-year to 4606000.0 in Q1 2026; TTM through Mar 2026 was 40007876.0, a 343.98% decrease from a year earlier, with the FY2025 full-year figure at 70690000.0, down 711.45% from the prior year.
- Income from Continuing Operations climbed to 4606000.0 in Q1 2026 per PFSA's latest filing, from 4648000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 3708996.0 in Q1 2022 and bottomed at 22557000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 367345.0 (2023), against an average of 2440948.06.
- Across the five-year window, Income from Continuing Operations soared 124.82% in 2024 and slumped 24839.79% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 519485.0 in 2022, then sank by 59.06% to 212692.0 in 2023, then sank by 3666.2% to 7585032.0 in 2024, then jumped by 38.72% to 4648000.0 in 2025, then increased by 0.9% to 4606000.0 in 2026.
- Per Business Quant, the three latest PFSA Income from Continuing Operations figures stand at 4606000.0 (Q1 2026), 4648000.0 (Q4 2025), and 22557000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | -4.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.61 Mn |
| Dec 31, 2025 | -4.65 Mn |
| Sep 30, 2025 | -22.56 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | -1.12 Mn |
| Dec 31, 2024 | -7.59 Mn |
| Sep 30, 2024 | 91,177.00 |
| Jun 30, 2024 | -397,487.00 |
| Mar 31, 2024 | -820,277.00 |
| Dec 31, 2023 | 212,692.00 |
| Sep 30, 2023 | -367,345.00 |
| Jun 30, 2023 | 852,389.00 |
| Mar 31, 2023 | 440,895.00 |
| Dec 31, 2022 | 519,485.00 |
| Sep 30, 2022 | 1.76 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | 3.71 Mn |